| DANAHER CORP. DL-,01 |
| USA |
| Gesundheit |
| US2358511028 / 866197 |
| DAP (Frankfurt) / DHR (NYSE) |
| FRA:DAP, ETR:DAP, DAP:GR, NYSE:DHR |
| S&P500 |
| https://www.danaher.com/ |
|
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services globally, with a primary focus on the United States, China, and other international markets. Operating through three key segm..
>Volltext.. |
| 117156.34 Mio. EUR |
| 130017.89 Mio. EUR |
| 20883.79 Mio. EUR |
| 6544.46 Mio. EUR |
| 3072.05 Mio. EUR |
| 4.32 EUR |
| 16742.39 Mio. EUR |
| 3922.94 Mio. EUR |
| 5453.86 Mio. EUR |
| 0.68 |
| -9.3% |
| -18.3% |
| 1.17 EUR |
| 0.7% |
| 0.82% |
| 27.03.26 - 0.3472€ 29.12.25 - 0.27174398€ >weitere anzeigen... |
| - |
| DANAHER |
| 21.04.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|